Landscapes / Targets

FLT3

19 drugs act on FLT3, in 41 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs19

DrugHow it worksCompanyStageNext dateDetails
Tyrosine kinase inhibitor
Approved 1 May 2027Phase 1/2 trial completes
Tyrosine kinase inhibitor
Approved 31 Jul 2028Phase 1/2 trial completes
Kinase inhibitor
Approved —
—
Phase 3 30 Dec 2026Phase 3 trial completes
—
Phase 3 1 Jul 2027Phase 3 trial completes
Flonoltinibnot checked
Tyrosine kinase inhibitor
Phase 3 30 Jul 2027Phase 2 trial completes
Tyrosine kinase inhibitor
Phase 3 29 Nov 2027Phase 2 trial completes
Clifutinibnot checked
Tyrosine kinase inhibitor
Phase 3 30 Nov 2027Phase 3 trial completes
Tyrosine kinase inhibitor
Phase 1/2 Nov 2026soonPhase 1/2 trial completes
—
Phase 2 Dec 2026Phase 2 trial completes
—
Phase 2 1 Sep 2027Phase 2 trial completes
Pacritinibnot checked
Kinase inhibitor
Phase 2 Jul 2028Phase 2 trial completes
—
Phase 1/2 30 Dec 2029Phase 1/2 trial completes
—
Phase 1 Jan 2027Phase 1 trial completes
—
Phase 1 7 Mar 2027Phase 1 trial completes
—
Phase 1 Jun 2027Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —
—
Phase 1 —

About this list

Checked
16 of 19 drugs. The other 3 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow FLT3

Following is part of Solo: you see every change to FLT3 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in